Zachariah Chowdhury | Medicine and Dentistry | Best Researcher Award

Posted on by Shen Awards

Dr. Zachariah Chowdhury | Medicine and Dentistry | Best Researcher Award

Professor, Dept Of Oncopathology from Mahamana Pandit Madan Mohan Malviya Cancer Centre (Tata Memorial Hospital) Varanasi, India

Dr. Zachariah Chowdhury is an accomplished academician, clinician, and researcher in the field of oncopathology, currently serving as the Professor and Officer-in-Charge of the Department of OncoPathology at the Mahamana Pandit Madan Mohan Malaviya Cancer Centre (MPMMCC) & Homi Bhabha Cancer Hospital (HBCH) in Varanasi, under the Tata Memorial Centre. With foundational training in MBBS and MD in Pathology from Assam Medical College and a UICC Fellowship in Oncopathology, he has demonstrated an unwavering commitment to excellence in pathology and cancer diagnostics. His extensive teaching background includes instruction at multiple academic levels, including DM, MD, MBBS, nursing, and laboratory technology programs. Dr. Chowdhury has amassed an impressive portfolio of over 50 peer-reviewed publications, addressing both common and rare oncological conditions, contributing significantly to the evolving understanding of oncopathology. He is recognized for his comprehensive approach that merges histopathology, cytopathology, hematopathology, and molecular pathology. As a reviewer, invited speaker, and research presenter at both national and international platforms, he exemplifies the qualities of a dedicated and visionary medical researcher. His contributions to both clinical practice and research make him a pivotal figure in the Indian medical community and a strong candidate for national and international honors in the field of cancer pathology.

Professional Profile

Education

Dr. Chowdhury’s academic journey began with outstanding scholastic achievements, securing the 5th rank in his Higher Secondary School Examination from Cotton College, Guwahati, with a remarkable 83.6% score. He earned his MBBS from Assam Medical College under Dibrugarh University in 2004, ranking 2nd in his final examinations. His dedication to medical sciences continued with an MD in Pathology in 2011 from the same institution, where he again demonstrated academic excellence by clearing all examinations in his first attempt. Complementing his postgraduate training, Dr. Chowdhury was awarded the prestigious UICC/Dr. Praful Desai Fellowship in Oncopathology at Tata Memorial Centre, Mumbai, where he further honed his expertise in histopathology, cytopathology, and molecular diagnostics. Additionally, he underwent advanced training in molecular pathology at Tata Medical Centre, Kolkata, and Tata Memorial Centre, Parel, reinforcing his foundation in modern cancer diagnostics. His academic credentials are supported by multiple merit certificates from the Assam Higher Secondary Education Council, All Assam Students Union, and Assam Medical College, highlighting consistent academic distinction from secondary education through to his postgraduate years. This strong educational foundation has enabled Dr. Chowdhury to effectively lead both clinical and academic responsibilities in the field of oncopathology.

Professional Experience

Dr. Zachariah Chowdhury has accumulated rich and diverse professional experience across multiple prestigious institutions. He began his teaching career as a Senior Resident Doctor at the North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences (NEIGRIHMS), Shillong, where he served for three years post-MD, laying a strong foundation in clinical pathology and academic instruction. Currently, he serves as Professor and Officer-in-Charge of the Department of OncoPathology at MPMMCC & HBCH in Varanasi, both units under the Tata Memorial Centre. In this leadership role, he oversees academic training and diagnostic services in a high-volume cancer care setting. Dr. Chowdhury’s responsibilities include teaching DM (OncoPathology), MD (Pathology), MBBS, nursing, and laboratory science students in both theory and laboratory environments. His clinical expertise encompasses a wide spectrum, including histopathology, cytopathology, hematopathology, molecular diagnostics, clinical pathology, renal pathology, immunopathology, and blood banking. Additionally, he plays an active role in quality assurance programs within the diagnostic laboratory. Beyond his hospital commitments, he contributes to academia as a peer reviewer for multiple reputed medical journals and participates in national and international conferences as a speaker, panelist, and faculty. This blend of academic, clinical, and leadership experience underscores his stature as a seasoned medical professional.

Research Interest

Dr. Chowdhury’s research interests center around oncopathology with a multidisciplinary focus that integrates histopathology, molecular pathology, cytopathology, and hematopathology. His scholarly work investigates a wide range of oncological conditions, including breast cancer, thyroid lesions, ovarian tumors, pediatric malignancies, head and neck cancers, and hematolymphoid neoplasms. A key area of his research explores the diagnostic challenges and spectrum of rare tumors such as salivary gland neoplasms, solitary fibrous tumors, and angiosarcomas, with a special emphasis on cytohistological correlations and immunomorphological profiling. Additionally, he has contributed to understanding emerging themes like artificial intelligence in histopathology and the role of molecular diagnostics in rare malignancies. His recent studies include real-world clinical data on metastatic cancers and chemotherapy outcomes, bridging clinical practice with diagnostic research. Dr. Chowdhury’s commitment to evidence-based pathology is evident in his methodical approach to publishing both retrospective reviews and case-based literature, offering valuable insights to the global oncopathology community. His collaborations with multidisciplinary teams from oncology, radiology, and surgery reflect his integrative research philosophy. By focusing on both common diagnostic patterns and rare, underreported entities, his work not only advances academic pathology but also significantly contributes to clinical decision-making and patient outcomes.

Research Skills

Dr. Zachariah Chowdhury brings to the research landscape a comprehensive skill set encompassing classical and modern pathology techniques. He is proficient in histological examination, cytopathological evaluations (including FNAC and core biopsies), hematopathology analyses, and cutting-edge molecular diagnostics. His training at leading cancer centers like Tata Memorial Centre and Tata Medical Centre has equipped him with practical expertise in PCR, FISH, and immunohistochemistry techniques—essential tools in the molecular characterization of tumors. He also has expertise in immunomorphology and has applied these skills across a broad range of clinical cases, from pediatric cancers to high-grade lymphomas and soft tissue tumors. Dr. Chowdhury is also skilled in academic writing and statistical analysis, as evidenced by his extensive publication record across peer-reviewed indexed journals. His systematic approach to clinical audits, retrospective analyses, and diagnostic algorithm development further highlight his research rigor. Additionally, he has contributed to AI applications in cancer diagnosis, showcasing adaptability to new technologies. His experience in organizing research presentations and mentoring junior faculty and students also reflects strong leadership and team management skills within research settings. Altogether, his multidimensional research skills strongly align with the goals of translational oncology and precision medicine.

Awards and Honors

Dr. Chowdhury’s illustrious career has been recognized with numerous awards and honors, validating his significant impact in the field of pathology. Among the most notable are the Bharat Gaurav Puraskar (2023) and the Jewel of India Award (2024), both conferred by the KTK Outstanding Achievers and Education Foundation, New Delhi, for his exemplary contributions to pathology and medical education. During his academic years, he received multiple certificates of merit for academic excellence, including top ranks in both secondary and medical school examinations. His postgraduate performance earned him a Certificate of Merit from Assam Medical College. As a faculty member and researcher, he has consistently excelled in academic events, winning the first prize in Oral Paper Presentation at the 5th International Pediatric Pathology Conference (2022) and the Poster Presentation at NEIGRIHMS Annual Research Day (2018). His early career awards also include the North Eastern Council (NEC) Scholarship for MBBS, which supported his foundational medical education. Beyond these, his recognition extends to being a respected reviewer for multiple journals, and his frequent roles as invited speaker and panelist at various conferences. These accolades reflect both peer and institutional acknowledgment of his enduring impact on medical research and education.

Conclusion

Dr. Zachariah Chowdhury exemplifies the ideals of a clinician-scientist dedicated to excellence in oncopathology. With a firm grounding in both classical pathology and modern diagnostic innovations, he bridges the gap between histological diagnosis and translational cancer research. His career reflects a rare combination of clinical acumen, academic mentorship, research productivity, and institutional leadership. Through his prolific authorship of over 50 peer-reviewed publications, he contributes actively to the global understanding of complex and rare oncological entities. His commitment to education is evident in his multi-level teaching engagements and ongoing mentorship of pathology trainees. Dr. Chowdhury’s recognition through multiple national honors and academic awards further substantiates his role as a leading figure in cancer pathology in India. While already operating at a high level of academic and clinical distinction, future initiatives such as enhanced international collaborations, grant-funded research, and patent development would elevate his profile even further. Overall, Dr. Chowdhury represents a distinguished and highly qualified candidate for any recognition aimed at honoring pathologists and researchers who make substantial contributions to medical science, and particularly, to the evolving discipline of oncopathology.

Publications Top Notes

1. The many faces of ovarian sex cord stromal tumors: a clinicopathological analysis at a tertiary cancer center in North India

  • Year: 2025

  • Authors: Chowdhury Z, Agrawal S, Gupta S, Rai S, Jethani R, Saha S, Ranjan R, Pal A

  • Journal: Surgical and Experimental Pathology

2. The Myriad Spectrum of Salivary Gland Lesions: Cytohistological Correlation on Fine Needle Aspiration Cytology, Core Needle Biopsy, and Resections in a 5-Year Single Institutional Experience of North India

  • Year: 2025

  • Authors: Chowdhury Z, Majumdar P, Narain S, Lamba K

  • Journal: Diagnostic Cytopathology

3. ALK-positive large B-cell lymphoma: A study of six cases from an oncopathology center in North India

  • Year: 2025

  • Authors: Verma A, Chowdhury Z, Singh A, Kant A, Yadav A, Patne SCU

  • Journal: Indian Journal of Pathology and Microbiology

4. Cyto-Histomorphological Analysis of Thyroid Lesions and Risk Assessment of Malignancy/Neoplasia: Insights from a North Indian Tertiary Oncology Center

  • Year: 2025

  • Authors: Haiyat S, Chowdhury Z, Rudra Pal P, Patne S, Dhal I, Paul P

  • Journal: Cureus

5. An Analysis of Pediatric Round Cell Tumors Highlighting the Spectrum of Differential Diagnosis – A Single Center Experience and Systematic Review of Literature

  • Year: 2025

  • Authors: Dhal I, Lali BS, Rai H, Chowdhury Z, Patne S, Tripathi P, Saha S

  • Journal: International Journal of Scientific Studies

6. Real-world data on trastuzumab emtansine (TDM1) efficacy and safety: Results of a single-centre retrospective study of HER2-positive metastatic breast cancer patients

  • Year: 2025

  • Authors: Gupta A, Sansar B, Mishra BK, Khan A, Singh A, Upadhyay A, Chowdhury Z, Patne S, Tripathi M, et al.

  • Journal: Scientific Reports

7. Triple Oral Metronomic Chemotherapy Versus Chemotherapy of Physician Discretion After Failure of Platinum-Based Therapy in Advanced Head and Neck Cancer: A Phase III Randomized Study (METRO-CHASE Study)

  • Year: 2025

  • Authors: Kapoor A, Gupta A, Sansar B, Mishra BK, Gupta P, Singh A, Upadhyay A, Kashyap L, Pal A, Kumar A, Nanda SS, Mukherji A, Kapoor AR, Pradhan S, Mishra A, Chowdhury Z, Patne S, Dhal I, Singh N, et al.

  • Journal: JCO Global Oncology

8. Exploring Solitary Fibrous Tumors at a Tertiary Cancer Center: Clinicopathological and Immunomorphologic Profile

  • Year: 2024

  • Authors: Chowdhury Z, Mishrikotkar S, Nehra P, Patne S, Tripathi M

  • Journal: Cureus

9. A Review of the Applications of Artificial Intelligence in Histopathology

  • Year: 2024

  • Authors: Kandarpa S, Chowdhury Z, Pal PR, Rajput K, Saraf SA

  • Journal: Journal of Cancer Research Reviews & Reports

10. Outcomes of De Novo Oligometastatic Breast Cancer Treated With Surgery of Primary and Metastasis Directed Radiotherapy

  • Year: 2024

  • Authors: Pujari L, Suresh A, Chowdhury Z, Pradhan S, Tripathi M, Gupta A, Singh P, Giridhar P, Kapoor AR, Shinghal A, Sansar B, Mv M

  • Journal: American Journal of Clinical Oncology

 

Nobuhiro Takahashi | Medicine and Dentistry | Best Researcher Award

Posted on by Shen Awards

Dr. Nobuhiro Takahashi | Medicine and Dentistry | Best Researcher Award

Dermatologist from Tokai University School of Medicine, Japan

Dr. Nobuhiro Takahashi is a dedicated clinical professional specializing in dermatology, with a primary focus on inflammatory skin diseases. Currently serving as a Clinical Assistant in the Department of Dermatology at Tokai University Hospital, Kanagawa, Japan, Dr. Takahashi actively participates in both clinical practice and academic training. He has demonstrated a strong commitment to advancing patient care in outpatient dermatology. His work reflects a growing interest in combining clinical insights with research opportunities. With a solid foundation in medical education and practical experience, Dr. Takahashi shows promise for contributing significantly to dermatological research in the future.

Professional Profile

Education

Dr. Nobuhiro Takahashi completed his medical degree at Tokai University School of Medicine, Japan, graduating in March 2020. His academic training provided him with a comprehensive understanding of medical sciences, with a particular interest in dermatology developing during his studies. The rigorous curriculum at Tokai University laid the groundwork for his clinical reasoning, diagnostic skills, and patient management techniques. His education emphasized both theoretical knowledge and practical application, preparing him effectively for postgraduate clinical training and his current clinical role. Dr. Takahashi’s education continues to support his professional development and potential future contributions to clinical research.

Professional Experience

Dr. Takahashi began his professional journey as a Clinical Resident at Tokai University Hospital, where he completed a two-year postgraduate clinical training program from April 2020 to March 2022. This experience allowed him to build strong diagnostic and treatment skills across multiple medical disciplines. Since April 2022, he has been serving as a Clinical Assistant in the Department of Dermatology at Tokai University. In this role, he focuses on outpatient clinical dermatology and academic training, working closely with specialists to manage a variety of dermatological conditions. His current responsibilities allow him to blend clinical service with ongoing professional growth.

Research Interest

Dr. Takahashi’s primary research interests center around dermatology, particularly the study and management of inflammatory skin diseases. He is focused on improving clinical outcomes and advancing therapeutic strategies for these complex skin conditions. His exposure to diverse patient cases in an outpatient setting provides valuable clinical observations that can guide his research direction. While his current profile does not extensively detail research projects or publications, his interest in bridging clinical practice with academic research is evident. Dr. Takahashi is well-positioned to contribute to future dermatological studies that address common and challenging skin disorders.

Research Skills

Dr. Takahashi has developed a strong set of clinical and observational skills through his extensive outpatient dermatology practice. His ability to diagnose, monitor, and manage various skin conditions equips him with firsthand clinical insights essential for relevant and impactful research. Although specific laboratory or advanced research techniques are not detailed in his profile, his clinical experience supports potential development in clinical research methodologies, case study analysis, and patient-centered research. His ongoing academic training is expected to enhance his research capabilities further, enabling him to contribute to clinical trials and evidence-based dermatology studies.

Award and Honors

At this stage of his career, Dr. Takahashi has not yet received formal awards or honors in the field of dermatology or medical research. His professional achievements thus far reflect his dedication to clinical practice and academic growth. As he continues to develop his research portfolio and engage in scholarly activities, there is significant potential for him to earn recognition in the future. Participation in conferences, collaborative research, and contributions to peer-reviewed publications will likely pave the way for future awards and academic honors that acknowledge his efforts in advancing dermatological science.

Conclusion

In conclusion, Dr. Nobuhiro Takahashi is an emerging clinical dermatologist with a promising future in research. His solid educational background, hands-on clinical experience, and keen interest in inflammatory skin diseases demonstrate his dedication to the field. Although he currently has limited research output and formal recognitions, his trajectory indicates potential for future contributions to dermatological science. With continued clinical engagement, research involvement, and academic participation, Dr. Takahashi can develop into a respected researcher who significantly impacts both patient care and dermatological research. His career is well-positioned for continued growth and achievement.

Publication Top Note

  1. Title: A Case of Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma
  • Journal: JEADV Clinical Practice
  • Year: 2025

 

Susumu Eguchi | Medicine and Dentistry | Best Researcher Award

Posted on by Shen Awards

Prof. Susumu Eguchi | Medicine and Dentistry | Best Researcher Award

Professor and Chairman from Nagasaki University Graduate School of Biomedical Sciences, Japan

Dr. Susumu Eguchi, M.D., Ph.D., F.A.C.S., F.E.B.S., is a globally recognized expert in the field of liver transplantation, hepatobiliary (HPB) surgery, and regenerative medicine. As a Professor and Chairman at the Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences, Dr. Eguchi has demonstrated outstanding leadership in both clinical and academic arenas. His medical journey is marked by international exposure, significant research contributions, and a wide array of prestigious editorial appointments. He has actively shaped the advancement of liver surgery, particularly focusing on liver regeneration and hepatocyte-based therapies. Dr. Eguchi’s dedication extends beyond national boundaries, with ongoing collaborations as a visiting professor in China and Kazakhstan, strengthening cross-cultural medical education and research. His active participation in hospital management, international medical center leadership, and nuclear disaster preparedness showcases his multifaceted expertise. Additionally, his editorial influence in several leading surgical and transplantation journals underlines his authority and commitment to knowledge dissemination. Throughout his distinguished career, Dr. Eguchi has significantly contributed to the global medical community and is highly regarded for his ability to combine innovative research with practical surgical excellence. His holistic approach and deep impact in the field make him a prominent figure deserving international recognition.

Professional Profile

Education

Dr. Susumu Eguchi’s educational journey is marked by rigorous academic training and international exposure that shaped his expertise in surgery and transplantation. He graduated from the Nagasaki University School of Medicine in 1992, where he developed a solid foundation in medical sciences. His dedication to deepening his knowledge led him to pursue a Ph.D. at the Nagasaki University Graduate School of Biomedical Sciences, Department of Surgery, from April 1994 to March 1998. This doctoral program was pivotal in advancing his surgical and research competencies, particularly in the hepatobiliary and liver transplantation domains. His international perspective was further broadened during his time at Cedars-Sinai Medical Center in the United States from 1994 to 1997, where he gained valuable experience in surgical research. Dr. Eguchi’s education provided him with a comprehensive blend of clinical, academic, and research-based learning that later translated into his significant contributions to the surgical field. The integration of both Japanese and Western medical training environments equipped him with a unique ability to lead innovative research and clinical practices. His academic progression reflects a consistent pursuit of excellence and positioned him to become an influential leader in liver transplantation and regenerative medicine.

Professional Experience

Dr. Susumu Eguchi has an extensive and distinguished professional career spanning over three decades, characterized by leadership roles in clinical practice, international collaborations, and academic governance. His journey began as a surgical trainee at Nagasaki University Hospital, and he further honed his skills at Cedars-Sinai Medical Center, focusing on surgical research. He has served in key positions such as Chief of Surgery at various hospitals, including National Tsushima Hospital and Nakatsushima Hospital. His international clinical fellowship at Groningen University Hospital in the Netherlands specialized in liver transplantation and hepatobiliary surgery, deepening his expertise in these fields. Since 2012, he has been a Professor at Nagasaki University Graduate School of Biomedical Sciences, where he also took on administrative roles, including Deputy Hospital Director and Director of the International Medical Center and Transplant Center. His global influence is evident through his visiting professorship at Guangzhou First Municipal People’s Hospital and Professor Emeritus roles at prestigious institutions in Kazakhstan and China. Dr. Eguchi’s career reflects a perfect balance of surgical excellence, academic leadership, and international outreach. His continuous involvement in both patient care and research highlights his dedication to advancing surgical techniques and improving patient outcomes globally.

Research Interest

Dr. Susumu Eguchi’s research interests are centered around advancing liver transplantation, hepatobiliary surgery, liver regeneration, and regenerative medicine. His work has significantly contributed to the development of liver surgery techniques and the enhancement of liver transplantation outcomes. A major focus of his research involves hepatocyte-based therapy, exploring the potential of regenerative treatments to restore liver function and improve long-term survival rates for patients. Dr. Eguchi is also deeply invested in liver regeneration studies, aiming to unravel cellular and molecular mechanisms that can accelerate or support liver recovery after surgery or damage. His commitment to hepatobiliary and pancreatic (HPB) surgery research integrates both clinical advancements and innovative therapies, addressing complex surgical challenges. Additionally, Dr. Eguchi has shown interest in disaster response and medical preparedness, applying his medical leadership to nuclear disaster situations. His broad research spectrum allows him to contribute to multidisciplinary fields, including surgical innovation, organ preservation, and post-operative recovery strategies. With his global perspective and cross-institutional collaborations, Dr. Eguchi continues to drive progress in improving surgical outcomes and patient care. His pioneering research offers promising solutions in regenerative medicine and solid organ transplantation, pushing the boundaries of modern surgical practices.

Research Skills

Dr. Susumu Eguchi possesses a wide range of research skills that reflect his technical mastery and innovative approach in the field of surgery and transplantation. He is highly skilled in complex liver surgery, hepatobiliary surgical techniques, and organ transplantation procedures. His research capabilities encompass hepatocyte-based therapy development, liver regeneration studies, and regenerative medicine applications. Dr. Eguchi is adept at designing clinical trials, managing multi-institutional research projects, and applying translational research principles to bridge laboratory findings with patient care improvements. His leadership in surgical research has been recognized internationally, contributing to advancements in both surgical methodologies and post-operative patient management. Moreover, Dr. Eguchi demonstrates strong skills in cross-cultural medical collaboration, contributing to the development of global treatment standards. His editorial roles across multiple high-impact journals also indicate his proficiency in critical peer review, scientific writing, and knowledge dissemination. He is experienced in guiding surgical teams, mentoring young researchers, and overseeing international research initiatives. Additionally, his involvement in disaster preparedness reflects his ability to integrate surgical expertise with public health strategies. Dr. Eguchi’s exceptional surgical and research skills collectively position him as a leading figure in the evolution of liver surgery and transplantation.

Awards and Honors

Dr. Susumu Eguchi has received numerous prestigious certifications and honors throughout his distinguished career, which underline his excellence and global recognition in the surgical community. He is a Fellow of the American College of Surgeons (F.A.C.S.), a Fellow of the European Board of Surgery (F.E.B.S.), a Fellow of the International College of Surgeons (F.I.C.S.), and has been recognized as an IASGO Fellow (FASGO) since 2023. His leadership and contributions have earned him honorary titles, such as Professor Emeritus at both Syzganovs’ National Scientific Centre of Surgery in Kazakhstan and The Second Affiliated Hospital to Nanchang University in China. Dr. Eguchi’s exceptional academic contributions are further demonstrated through his numerous editorial appointments in influential journals, including Transplantation, SURGERY, Hepatology Research, Journal of Hepato-Biliary-Pancreatic Science, and Annals of Gastroenterological Surgery. His editorial influence reflects his standing as an expert in the field and his commitment to advancing global surgical knowledge. These accolades not only validate his exceptional skills and research contributions but also emphasize his role as an international leader and innovator in liver transplantation and hepatobiliary surgery.

Conclusion

In conclusion, Dr. Susumu Eguchi is an outstanding and highly accomplished surgeon, educator, and researcher whose contributions to the fields of liver transplantation, hepatobiliary surgery, and regenerative medicine have had a profound impact both in Japan and internationally. His career is marked by an exceptional blend of clinical excellence, academic leadership, and global collaboration. Dr. Eguchi’s extensive research into liver regeneration and hepatocyte-based therapy offers significant advancements in surgical techniques and patient care. His ability to successfully bridge international academic relationships, lead hospital departments, and manage disaster preparedness initiatives highlights his multifaceted expertise. His prestigious fellowships, editorial leadership roles, and international professorships further attest to his global influence and professional recognition. Although future efforts to showcase quantitative research impact, such as citation metrics, could further solidify his academic profile, his achievements to date are exemplary. Dr. Eguchi continues to inspire the next generation of surgeons and researchers through his innovative work, extensive mentorship, and dedication to improving liver surgery outcomes worldwide. Based on his contributions and leadership, he is an exceptional candidate for recognition as a leading researcher and an ideal recipient of the Best Researcher Award.

Publications Top Notes

1. Transplantation of chemically induced liver progenitors in Nagase analbuminemic rats under liver regenerative stimulus

Authors: Masayuki Fukumoto, Akihiko Soyama, Daisuke Miyamoto, Takanobu Hara, Hajime Matsushima, Hajime Imamura, Mampei Yamashita, Tomohiko Adachi, Kengo Kanetaka, Susumu Eguchi
Year: 2025

2. Association Between Distance to the Transplant Center and Survival Following Living Donor Liver Transplantation

Authors: Hajime Matsushima, Akihiko Soyama, Takanobu Hara, Ayaka Kinoshita, Takashi Hamada, Kazushige Migita, Ayaka Satoh, Hajime Imamura, Tomohiko Adachi, Susumu Eguchi
Year: 2025

3. Effect on short‐term outcomes of the COVID‐19 pandemic following laparoscopic distal gastrectomy and low anterior resection for gastric and rectal cancer: A retrospective study using the Japanese National Clinical Database, 2018–2022

Authors: Masafumi Inomata, Hideki Endo, Tomonori Akagi, Hidefumi Shiroshita, Shigeki Yamaguchi, Susumu Eguchi, Norihito Wada, Yukinori Kurokawa, Yosuke Seki, Yoshiharu Sakai, et al.
Year: 2025

4. Limitations of the proposed lymph node classification in intrahepatic cholangiocarcinoma

Author: Susumu Eguchi
Year: 2025

5. Annual report on National Clinical Database 2021 for gastroenterological surgery in Japan

Authors: Sunao Ito, Arata Takahashi, Hideki Ueno, Shuji Takiguchi, Yoshiki Kajiwara, Yoshihiro Kakeji, Susumu Eguchi, Takanori Goi, Akio Saiura, Akira Sasaki, et al.
Year: 2025

6. Histopathological Downgrading of Borderline Phyllodes Tumor in a Young Patient Following Chemotherapy: A Case Report

Authors: Yuki Hara, Rin Yamaguchi, Ryota Otsubo, Ayako Fukushima, Eiko Inamasu, Momoko Akashi, Michi Morita, Sayaka Kuba, Susumu Eguchi, Keitaro Matsumoto
Year: 2024

7. Efficacy of chemically induced human hepatic progenitor cells from diseased liver against nonalcoholic steatohepatitis model

Authors: Daisuke Miyamoto, Kunihito Matsuguma, Kazuhiro Nagai, Takayuki Miyoshi, Takanobu Hara, Hajime Matsushima, Akihiko Soyama, Takahiro Ochiya, Yasushi Miyazaki, Susumu Eguchi
Year: 2024

8. Current status and future perspectives of robotic liver surgery

Authors: Akihiko Soyama, Takashi Hamada, Tomohiko Adachi, Susumu Eguchi
Year: 2024

9. Essential updates 2022/2023: A review of current topics in robotic hepatectomy

Authors: Tomohiko Adachi, Takanobu Hara, Hajime Matsushima, Akihiko Soyama, Susumu Eguchi
Year: 2024

10. Short‐term outcomes after liver resection with vascular reconstruction: Results from a study with the National Clinical Database of Japan

Authors: Akihiko Soyama, Hiroyuki Yamamoto, Susumu Eguchi, Atsushi Nanashima, Yoshihiro Kakeji, Yuko Kitagawa, Masafumi Nakamura, Itaru Endo
Year: 2024

Guoguo Jin | Medicine and Dentistry | Best Researcher Award

Posted on by Shen Awards

Assoc. Prof. Dr. Guoguo Jin | Medicine and Dentistry | Best Researcher Award

Deputy Director from Key Laboratory of Chronic Disease Health Management of Henan Province, China

Dr. Guoguo Jin is an accomplished biomedical researcher specializing in the chemical prevention of tumors. With a strong foundation in pathology and bioengineering, she has steadily developed a research career that bridges cancer biology and cardiovascular complications arising from oncological treatments. Her work delves into the molecular mechanisms underlying tumorigenesis, cardiotoxicity from chemotherapeutic agents, and the identification of therapeutic targets for various cancers, particularly esophageal, gastric, and colon carcinomas. Dr. Jin currently serves as the Deputy Director of both the Key Laboratory of Chronic Disease Health Management and the Department of Scientific Research and Discipline Construction at Fuwai Central China Cardiovascular Hospital. She has led several national and provincial-level research projects and has published extensively in top-tier journals. Her research contributions are complemented by multiple patents aimed at mitigating drug-induced cardiotoxicity. Recognized for her leadership and scientific acumen, she has received accolades such as the Young and Middle-aged Academic Leader title from the Health Commission of Henan Province. Overall, Dr. Jin’s work represents a compelling blend of scientific rigor, clinical relevance, and translational potential. Her continued efforts are likely to yield significant advancements in cancer therapy and patient care.

Professional Profile

Education

Dr. Guoguo Jin began her academic journey in bioengineering, earning her Master’s degree from the School of Bioengineering at Zhengzhou University in July 2011. This foundational training equipped her with critical insights into biomedical sciences and experimental techniques. She then pursued her doctoral studies in pathology and pathophysiology at the Basic Medical College of Zhengzhou University, receiving her Ph.D. in July 2017. During her doctoral program, she was selected for an international joint training opportunity and spent two years (2015–2017) at the prestigious Hormel Institute, University of Minnesota. There, she conducted in-depth research into the signal transduction pathways related to tumorigenesis and its prevention. Her time abroad not only enriched her technical competencies but also exposed her to cutting-edge methodologies in cancer biology. This combination of local and international academic training has laid a solid foundation for her ongoing research into tumor mechanisms and therapeutic strategies. Dr. Jin’s educational background reflects a trajectory of consistent academic excellence and scientific curiosity, establishing her as a capable and knowledgeable researcher in the fields of oncology and pathology.

Professional Experience

Dr. Guoguo Jin currently holds dual leadership roles at Fuwai Central China Cardiovascular Hospital, where she serves as Deputy Director of both the Key Laboratory of Chronic Disease Health Management of Henan Province and the Department of Scientific Research and Discipline Construction. Her professional responsibilities primarily involve overseeing tumor-related research and institutional academic development. Earlier in her career, she gained international experience at the Hormel Institute, University of Minnesota, where she focused on cancer signal transduction pathways. This exposure to high-impact research environments significantly influenced her approach to scientific inquiry. Throughout her career, Dr. Jin has successfully led multiple research projects funded at both national and provincial levels. These projects explore the molecular mechanisms of drug-induced cardiotoxicity, tumor progression, and the discovery of small-molecule inhibitors. Her clinical and translational research activities are closely integrated with her hospital’s goals, enhancing the relevance and impact of her findings. With a strong blend of laboratory management, project leadership, and interdepartmental coordination, Dr. Jin’s professional journey reflects her growth from a bench scientist to an influential figure in medical research administration. Her dual roles in scientific research and academic governance enable her to contribute meaningfully to both science and institutional progress.

Research Interest

Dr. Guoguo Jin’s primary research interest lies in the chemical prevention of tumors, with a focus on uncovering the molecular mechanisms that drive carcinogenesis and treatment-related complications. She is particularly interested in the pathways that regulate tumor initiation and progression in gastrointestinal cancers such as esophageal, gastric, and colon cancer. A significant portion of her work also explores the cardiotoxic effects of chemotherapeutic agents like osimertinib and doxorubicin, aiming to develop strategies to mitigate these adverse outcomes. Her recent studies have investigated the roles of signaling molecules such as WNK1, hnRNPU, AHCY-LDHA, and ZIP8 in cancer development and progression. Dr. Jin is also deeply involved in the identification and evaluation of small-molecule inhibitors and natural compounds like α-mangostin and curcumin for their anti-tumor efficacy. Her research bridges basic science and clinical application, positioning her work at the forefront of translational oncology. Through the development of targeted therapies and predictive biomarkers, she aims to improve both treatment outcomes and quality of life for cancer patients. This integrated focus on cancer biology and cardiotoxicity underlines her commitment to advancing personalized medicine in oncology.

Research Skills

Dr. Guoguo Jin possesses a wide array of research skills, especially in molecular and cellular biology techniques relevant to oncology. She is proficient in signal transduction analysis, gene expression profiling, histone modification studies, and functional validation of oncogenes and tumor suppressors. Her expertise extends to the use of in vitro and in vivo cancer models to study the efficacy and mechanisms of chemopreventive agents. She has demonstrated a high level of competence in utilizing molecular techniques such as Western blotting, qRT-PCR, immunohistochemistry, and chromatin immunoprecipitation assays. Her postdoctoral training at the Hormel Institute allowed her to master advanced techniques for dissecting signaling pathways in cancer. In addition to experimental skills, Dr. Jin has a solid foundation in project design, grant writing, and data analysis. She is also skilled in translating laboratory findings into potential therapeutic applications, as demonstrated by her patents. Moreover, her ability to manage multidisciplinary teams and coordinate with clinical departments enhances the practical relevance of her research. These competencies enable her to effectively lead complex biomedical projects from conceptualization to execution and dissemination.

Awards and Honors

Dr. Guoguo Jin has received multiple awards and honors that underscore her impact and promise in the field of medical research. In February 2024, she was selected as a Young and Middle-aged Academic Leader in Health and Wellness by the Health Commission of Henan Province, a recognition of her leadership in translational cancer research. Later that year, she was awarded a position in the National-Level Talent Cultivation Project for First-Class Discipline in Clinical Medicine at Zhengzhou University. Dr. Jin has also secured several competitive research grants, including the National Natural Science Foundation Youth Project, the Science and Technology Tackling Project by the Department of Science and Technology of Henan Province, and the Outstanding Young Talent Training Program for Health and Technology Innovation. Her innovative research on cancer prevention and cardiotoxicity has led to two patents, further highlighting her commitment to developing clinically relevant solutions. These accolades reflect not only her scientific excellence but also her dedication to advancing health outcomes through rigorous and applied research. The consistent support from national and provincial agencies illustrates her status as a leading figure in her domain.

Conclusion

Dr. Guoguo Jin exemplifies the qualities of a leading researcher with her focused expertise in chemical tumor prevention and translational oncology. Her well-rounded background—from robust academic training to leadership in high-impact research—positions her as a valuable contributor to both the scientific community and clinical practice. Her studies on molecular mechanisms of cancer progression and cardiotoxicity have not only expanded academic understanding but have also offered practical pathways for improving patient outcomes. Through national and provincial grants, influential publications, and patented innovations, she continues to push the boundaries of cancer therapy and prevention. While her research is already making a meaningful impact, future expansion into international collaborations and clinical trials could further elevate her contributions. Overall, Dr. Jin’s career is marked by scientific rigor, visionary leadership, and a commitment to translating research into real-world solutions. She is a highly deserving candidate for recognition through honors such as the Best Researcher Award and is likely to make even greater strides in cancer research in the years to come.

Publications Top Notes

  1. Title: STIP1 drives metabolic reprogramming in esophageal squamous cell carcinoma via AHCY-LDHA axis
    Authors: Jin G, Song Y, Yan M, Fang S, Shao Y, Zhao K, Liu M, Guo Q, Jia X, Zhang C, Wang Z, Liu K, Li X, Zhao S, Guo Z, Dong Z
    Year: 2025

  2. Title: hnRNPU-mediated pathogenic alternative splicing drives gastric cancer progression
    Authors: Jin G, Song Y, Fang S, Yan M, Yang Z, Shao Y, Zhao K, Liu M, Wang Z, Guo Z, Dong Z
    Year: 2025

  3. Title: ZIP8 modulates ferroptosis to drive esophageal carcinoma progression
    Authors: Yang Z, Zhao K, Li X, Yanzhang R, Zhang H, Yu Y, Yan M, Fang S, Li T, Li H, Chu X, Han S, Zhang Z, Teng J, Jin G, Guo Z
    Year: 2025

  4. Title: Discovery of a novel dual-target inhibitor against RSK1 and MSK2 to suppress growth of human colon cancer
    Authors: Jin G, Yan M, Liu K, Yao K, Chen H, Zhang C, Yi Y, Reddy K, Gorja DR, Laster KV, Guo Z, Dong Z
    Year: 2020

  5. Title: Ginger extract inhibits c-MET activation and suppresses osteosarcoma in vitro and in vivo
    Authors: Yanzhang R, Yan M, Yang Z, Zhang H, Yu Y, Li X, Shen R, Chu X, Han S, Zhang Z, Teng J, Li H, Li T, Jin G, Guo Z
    Year: 2025

  6. Title: PDK1-mediated phosphorylation of USP5 modulates NF-κB signalling to enhance osteosarcoma growth
    Authors: Yang Z, Yu Z, Teng J, Yanzhang R, Yu Y, Zhang H, Jin G, Wang F
    Year: 2025

  7. Title: Precision therapy for cancer prevention by targeting carcinogenesis
    Authors: Jin G, Liu K, Guo Z, Dong Z*
    Year: 2024

  8. Title: Decrypting the Molecular Mechanistic Pathways Delineating the Chemotherapeutic Potential of Ruthenium-Phloretin Complex in Colon Carcinoma Correlated with the Oxidative Status and Increased Apoptotic Events
    Authors: Jin G, Zhao Z, Chakraborty T, et al.
    Year: 2020

  9. Title: Aurora B kinase as a novel molecular target for inhibition the growth of osteosarcoma
    Authors: Zhao Z, Jin G, Yao K, Liu K, Liu F, Chen H, Wang K, Gorja DR, Reddy K, Bode A.M., Guo Z, Dong Z
    Year: 2019

  10. Title: Resveratrol suppresses colon cancer growth by targeting the AKT/STAT3 signaling pathway
    Authors: Li D, Wang G, Jin G, Yao K, Zhao Z, Bie L, Guo Y, Li N, Deng W, Chen X, Chen B, Liu Y, Luo S, Guo Z
    Year: 2019

Kumiko Tajima | Medicine and Dentistry | Women Researcher Award

Posted on by Shen Awards

Dr. Kumiko Tajima | Medicine and Dentistry | Women Researcher Award

Manager from Gunma Central Hospital, Japan

Kumiko Tajima is a highly qualified medical professional with extensive experience in internal medicine and diabetes care. She graduated from Gunma University School of Medicine in 1992 and completed graduate studies at Gunma University Graduate School in 1999. With over two decades of clinical practice, she has served at several prominent medical institutions in Japan, including Gunma University School of Medicine, National Takasaki Hospital, and Gunma Prefectural Cardiovascular Center. Since 2014, she has been practicing at Gunma Central Hospital. Kumiko is recognized as a certified physician by the Japanese Society of Internal Medicine and specializes in general internal medicine and diabetes management. Her career is marked by a strong commitment to patient care, education, and specialized training, including roles as an instructor for medical training programs. She also serves vulnerable populations as a designated physician for disabilities and intractable diseases. While her clinical expertise is well documented, her research involvement is not explicitly detailed in the information available, suggesting a potential focus on clinical practice and medical education over research output. Nevertheless, her professional credentials and dedication to healthcare highlight her as a respected figure in the medical community.

Professional Profile

Education

Kumiko Tajima completed her formal education at Gunma University, one of Japan’s reputable institutions. She graduated from the Gunma University School of Medicine in 1992, where she acquired the foundational knowledge and clinical skills required to pursue a medical career. Following her medical degree, she advanced her expertise by completing graduate studies at Gunma University Graduate School in 1999. This postgraduate education likely included clinical research or advanced medical training, equipping her with enhanced knowledge in medical sciences. Her educational background provided a strong base for her subsequent clinical work and certifications in various medical specialties. Being an alumna of the same university for both undergraduate and graduate studies suggests continuity and depth in her academic preparation. Her education set the stage for her later roles in internal medicine, diabetes specialization, and her involvement in training programs. The rigorous training at Gunma University, known for its emphasis on both research and clinical practice, has likely influenced her professional trajectory, balancing patient care with medical education.

Professional Experience

Kumiko Tajima has accumulated significant clinical experience working in multiple prestigious medical institutions across Japan. Early in her career, she worked at Gunma University School of Medicine, which provided her with exposure to academic medicine and clinical research environments. She also served at National Takasaki Hospital, Tatebayashi Kosei Hospital, and Gunma Prefectural Cardiovascular Center, gaining diverse experience in patient care across various specialties and healthcare settings. Since 2014, she has been a key medical professional at Gunma Central Hospital, where she continues to provide specialized care in internal medicine and diabetes management. Throughout her career, she has been recognized for her expertise by multiple Japanese medical societies, reflected in her qualifications as a certified physician and specialist. She holds important roles such as a training instructor for diabetes care and general medical training, indicating her leadership in mentoring younger physicians. Additionally, her designation as a physician under the Welfare Act for the Physically Disabled and for intractable diseases highlights her involvement in public health and complex patient populations. Her extensive clinical roles demonstrate a strong foundation in both patient care and medical education.

Research Interests

While explicit details about Kumiko Tajima’s research interests are not provided in the information available, it is reasonable to infer that her research focus aligns closely with her clinical specialties—internal medicine and diabetes. Given her certifications and instructor roles within the Japan Diabetes Society, she likely engages with research related to diabetes management, treatment outcomes, and possibly public health aspects of chronic diseases. Her designation as a physician responsible for intractable diseases suggests potential interest in complex, difficult-to-treat conditions that may require innovative clinical approaches or translational research. Moreover, her role in general medical training indicates a probable interest in medical education research or clinical practice improvement. Without specific publications or ongoing research projects mentioned, her primary contributions may be in applying clinical knowledge to patient care and educating the next generation of physicians. If involved in research, it may focus on improving clinical protocols, diabetes education, or interdisciplinary care for chronic disease patients. Confirmation of such interests would strengthen her profile as a clinician-researcher.

Research Skills

Kumiko Tajima’s documented expertise suggests strong clinical skills particularly in internal medicine, diabetes care, and training future medical professionals. As a certified specialist and instructor in diabetes, she likely possesses advanced skills in managing complex cases, interpreting clinical data, and applying evidence-based medicine. Her role as an industrial physician and designated physician for the disabled reflects proficiency in occupational health and specialized patient management. Although there is no explicit mention of laboratory or bench research skills, her graduate education and clinical roles imply familiarity with clinical research methodologies, patient data analysis, and possibly clinical trial participation. Her instructional roles also suggest capabilities in curriculum development, clinical supervision, and medical education, which are important research-adjacent skills. If involved in research activities, these skills would be foundational for clinical studies, epidemiological research, or healthcare quality improvement projects. To enhance her research profile, further skills in scientific writing, grant applications, and collaboration in research networks would be beneficial.

Awards and Honors

The provided information does not list any specific awards or honors received by Kumiko Tajima. However, her qualifications as a certified physician by reputable Japanese medical societies, and her appointment as a specially appointed instructor for general medical training, indicate professional recognition within the medical community. These certifications and instructor roles can be seen as professional honors reflecting her expertise and dedication to clinical excellence and education. Additionally, her designation as a physician for intractable diseases and disabilities suggests recognition of her specialized skills and trust placed in her by public health authorities. While no formal awards are cited, her career achievements and appointments demonstrate a high level of respect and acknowledgment from her peers and regulatory bodies. Should she have received awards related to clinical innovation, research contributions, or teaching excellence, including these would enhance her profile for awards specifically focused on research.

Conclusion

Kumiko Tajima is an experienced and highly qualified medical professional with strong credentials in internal medicine and diabetes care. Her clinical expertise, long-standing service in multiple hospitals, and roles in medical training and specialized care demonstrate her dedication to both patient health and medical education. While she holds numerous certifications and leadership roles within professional medical societies, her profile lacks explicit information on research outputs, publications, or scientific contributions. For a Women Researcher Award focused on research excellence, evidence of active research involvement or scholarly achievements would be necessary to strengthen her candidacy. Nevertheless, her commitment to specialized clinical care, training, and vulnerable patient populations underscores her valuable role in the healthcare system. If supplemented by further details on her research activities, Kumiko Tajima could be a strong candidate. Currently, her profile is more aligned with clinical leadership and education, rather than research-centric recognition.

Publications Top Notes

  1. A case of SHORT syndrome with a novel genetic mutation diagnosed 19 years after the onset of diabetes

    • Authors: Kumiko Tajima, Yushi Hirota, Tomofumi Takayoshi, Wataru Ogawa

    • Year: 2025

  2. Medical Mystery: Abnormal Abdominal Radiograph — The Answer

    • Authors: Masahiko Kurabayashi, Kumiko Tajima

    • Year: 2007

  3. Medical Mystery — Abnormal Abdominal Radiograph

    • Authors: Kumiko Tajima, Masahiko Kurabayashi

    • Year: 2006

Jiaqi Zhang | Medicine and Dentistry | Best Researcher Award

Posted on by Shen Awards

Dr. Jiaqi Zhang | Medicine and Dentistry | Best Researcher Award

Chief resident from Peking University Third Hospital, China

Dr. Jiaqi Zhang is currently serving as Chief Resident in the Department of Orthopedics at Peking University Third Hospital. A dedicated medical professional and clinical researcher, he has established a specialized focus on spinal deformities in adults, particularly those of complex and congenital origins. With a medical degree in orthopedics from the prestigious Peking University, Dr. Zhang integrates clinical expertise with rigorous research activities. He is also actively involved in academic research as part of the Beijing Key Laboratory of Spinal Disease Research and the Engineering Research Center of Bone and Joint Precision Medicine, affiliated with China’s Ministry of Education. Dr. Zhang has contributed to peer-reviewed literature, with five published articles in SCI-indexed journals that delve into advanced diagnostic imaging and surgical outcomes. His most notable contribution lies in identifying MRI indicators for poor prognosis in patients with congenital angular kyphosis, which has practical implications in spine surgery decision-making. Though early in his research career, Dr. Zhang is committed to advancing orthopedic science and improving patient care outcomes. He continues to develop his expertise through ongoing clinical research projects and aims to expand his impact through collaborative studies and innovation in spinal surgery.

Professional Profile

Education

Dr. Jiaqi Zhang earned his Doctor of Orthopedics degree from Peking University, one of China’s most esteemed medical institutions. His education laid a robust foundation in both theoretical and practical aspects of orthopedic surgery, with a growing focus on spinal deformities during his residency years. The program provided intensive clinical training combined with exposure to academic research, enabling him to understand the intricacies of musculoskeletal disorders at both clinical and cellular levels. In addition to his core medical training, Dr. Zhang engaged in independent studies and mentored research activities that emphasized evidence-based medicine, biomechanics, and diagnostic imaging. His thesis work and research outputs during the doctoral program reflected a deep interest in the surgical management of complex spinal conditions, an area which would later become his primary research focus. Peking University’s commitment to academic excellence, interdisciplinary research, and advanced medical technologies has played a crucial role in shaping Dr. Zhang’s clinical acumen and investigative mindset. The educational environment also allowed him to build competencies in surgical planning, patient care management, and ethical clinical research, positioning him to serve effectively in both hospital and academic settings.

Professional Experience

Dr. Jiaqi Zhang currently holds the position of Chief Resident in the Department of Orthopedics at Peking University Third Hospital, a leading medical institution in China. In this capacity, he manages a wide array of clinical responsibilities, ranging from patient diagnosis and pre-operative evaluations to complex spinal surgeries and post-operative care. His role demands a high degree of precision, leadership, and the ability to make swift, informed decisions in high-pressure environments. In parallel with his clinical duties, Dr. Zhang also serves as a researcher in the Beijing Key Laboratory of Spinal Disease Research and the Engineering Research Center of Bone and Joint Precision Medicine. These appointments allow him to participate in translational research efforts focused on improving the treatment and understanding of spinal disorders. Through these roles, Dr. Zhang has been actively involved in three major clinical research projects, integrating data analysis, surgical innovation, and radiological evaluation. His clinical insights feed directly into his research questions, creating a dynamic loop between patient care and scientific discovery. Although still in the early stages of his career, Dr. Zhang has demonstrated professional maturity and a strong commitment to interdisciplinary collaboration in both clinical and academic spheres.

Research Interests

Dr. Jiaqi Zhang’s research interests are centered around the surgical treatment and pathophysiological mechanisms of adult spinal deformity, with a specialized focus on rare and complex conditions such as congenital angular kyphosis. He is particularly interested in the intersection of diagnostic imaging and surgical outcomes, seeking to improve preoperative planning through advanced radiological markers. One of his primary research goals is to develop predictive models based on MRI indicators to identify patients at higher risk of poor neurological recovery. His study of compressive myelopathy associated with severe kyphosis is a reflection of this interest, where he demonstrated the value of quantifying MRI features such as T1WI hypointensity and MTAC ratios. Dr. Zhang also aims to explore how early surgical intervention can prevent irreversible spinal cord damage, with implications for refining surgical timing and techniques. His broader interests include spinal biomechanics, spinal cord injury recovery, and minimally invasive surgical innovations. Through evidence-based practice and rigorous analysis, he aspires to contribute to the development of clinical guidelines that enhance surgical decision-making and long-term patient outcomes. Future research plans include collaborating with biomedical engineers and radiologists to explore imaging-based AI models in spine surgery.

Research Skills

Dr. Jiaqi Zhang possesses a comprehensive set of research skills that complement his clinical expertise in orthopedic surgery. He is proficient in clinical research design, patient data analysis, and statistical interpretation, particularly in relation to outcome-based studies in spinal surgery. His methodological skills are reflected in his rigorous screening of patient cohorts and meticulous evaluation of radiological parameters, such as those used in his study on congenital angular kyphosis and myelopathy. He has hands-on experience with MRI data analysis and its integration into surgical planning, which enhances both predictive and outcome assessment models. Dr. Zhang is also familiar with scientific writing, literature review methodologies, and the publication process, as evidenced by his five publications in peer-reviewed, SCI-indexed journals. While he has yet to engage in industry collaborations or patent development, he shows potential to expand his research competencies through interdisciplinary projects. Additionally, he is comfortable working with medical imaging software and clinical databases, enabling him to bridge diagnostic tools with surgical interventions. His commitment to ethical standards in clinical research and informed consent processes further strengthens his skill set. As he continues his academic and clinical journey, Dr. Zhang aims to refine his skills in grant writing, protocol development, and advanced statistical tools.

Awards and Honors

As of the current application, Dr. Jiaqi Zhang has not listed any formal awards or honors. However, his selection as Chief Resident at Peking University Third Hospital is itself indicative of his academic and professional excellence. Chief residency is typically awarded to individuals who have demonstrated exceptional clinical skills, leadership capabilities, and research promise during their training. Additionally, his role as a researcher in the Beijing Key Laboratory of Spinal Disease Research and the Engineering Research Center of Bone and Joint Precision Medicine reflects institutional recognition of his potential to contribute meaningfully to high-impact research. While he may not yet have received formal accolades such as national awards or fellowships, Dr. Zhang is on a promising trajectory. His recent publications, innovative work in MRI-based surgical prognosis, and growing presence in peer-reviewed literature may soon garner greater professional recognition. As he continues to expand his academic portfolio through additional publications, collaborative projects, and advanced studies, he is likely to become a strong candidate for future awards and honors in both national and international orthopedic research communities.

Conclusion

Dr. Jiaqi Zhang is a dedicated clinician-researcher who exemplifies a balanced integration of academic rigor and clinical acumen. His research, though still in early stages, targets a highly specialized and clinically significant area—adult spinal deformity with neurologic complications. The outcomes of his studies provide practical guidance for surgeons in managing complex cases, particularly through the use of MRI-based prognostic markers. While his profile would benefit from broader research collaborations, industry partnerships, and increased visibility through awards or society memberships, his current contributions lay a strong foundation for future growth. With five SCI-indexed publications, three active research projects, and a leadership role as Chief Resident, Dr. Zhang has demonstrated a consistent commitment to advancing orthopedic science. His ability to translate clinical challenges into research questions, coupled with his skill in data-driven analysis, positions him as a rising contributor to the field of spinal surgery. In conclusion, Dr. Jiaqi Zhang has the potential to become a leading voice in orthopedic research, provided he continues to build on his current achievements with expanded collaborations and continued innovation.

Stephen Twumasi | Medicine and Dentistry | Best Researcher Award

Posted on by Shen Awards

Mr. Stephen Twumasi | Medicine and Dentistry | Best Researcher Award

Kwame Nkrumah University of Science and Technology, Ghana

Stephen Twumasi is an emerging biomedical researcher with a strong academic background in haematology and medical diagnostics. His academic and professional pursuits have been shaped by a passion for understanding the molecular and immunological mechanisms underlying human diseases, particularly in the context of cancer, infectious diseases, and hematological disorders. With an M.Phil. in Haematology from Kwame Nkrumah University of Science and Technology (KNUST), Ghana, and a B.Sc. in Medical Laboratory Science from the University of Cape Coast, he has demonstrated academic rigor and a deep interest in advancing health research. Stephen has actively pursued professional development through short courses in genomics, bioinformatics, systematic reviews, and community health entrepreneurship. His current research focuses on tumor immunology, developmental hematopoiesis, and molecular diagnostics for chronic and infectious diseases. Despite being in the early stages of his research career, he is keenly aware of the global health landscape and has aligned his work with critical health issues affecting Africa and beyond. With aspirations to make a meaningful contribution to global health research, Stephen combines his academic strength with continuous skill enhancement and a commitment to multidisciplinary inquiry.

Professional Profile

Education

Stephen Twumasi’s academic journey reflects a consistent focus on biomedical sciences and a deepening specialization in haematology. He earned his M.Phil. in Haematology from the Kwame Nkrumah University of Science and Technology (KNUST), Kumasi, Ghana, in 2024. With a cumulative weighted average of 69.40/100 (equivalent to a CGPA of 3.8/4.0) and a thesis graded ‘A’ (Pass), he displayed academic excellence and research capability in the program. Prior to his postgraduate studies, he obtained a Bachelor of Science in Medical Laboratory Science from the University of Cape Coast in 2020, graduating with a Second Class Honors (Upper Division) and a CGPA of 3.2/4.0. His foundational education began at Adventist Senior High School in Kumasi, where he completed his West Africa Senior School Certificate Examination (WASSCE) in 2015. In addition to formal education, Stephen has completed several short courses to broaden his knowledge and research skills. These include certifications in Genomics and Bioinformatics, Systematic Review and Meta-analyses, Research Writing for Publication, One Health Basics, and Community Health Entrepreneurship. His commitment to lifelong learning and interdisciplinary training places him in a strong position for advanced research and academic engagement.

Professional Experience

Stephen Twumasi’s professional experience is grounded in his academic training in medical diagnostics and laboratory science. While specific employment roles have not been listed, it is evident that his academic journey included substantial practical exposure and laboratory-based research, particularly during his M.Phil. studies in Haematology. His postgraduate thesis work required advanced skills in diagnostic hematology, interpretation of immunological markers, and laboratory-based experimentation, reflecting real-world clinical and research competence. Through his involvement in academic programs and training workshops, Stephen has gained experience in handling molecular biology protocols, data analysis, and diagnostic procedures that are critical in modern healthcare settings. His training in community health entrepreneurship also suggests a practical understanding of the healthcare ecosystem and how scientific research can be translated into community impact. Stephen’s practical experience is further enhanced by his completion of skill-based short courses offered by reputable institutions and international collaborators. These programs have allowed him to interact with health researchers across Africa and beyond, enriching his perspectives and research readiness. Though his formal professional roles may still be developing, Stephen has built a strong foundation in biomedical practice and research through hands-on learning and academic immersion.

Research Interest

Stephen Twumasi’s research interests are firmly anchored in immunology, hematology, and molecular diagnostics, with a multidisciplinary approach that reflects current global biomedical priorities. He is particularly interested in understanding the immunological and molecular changes that occur within the tumor microenvironment and how these changes influence cancer progression, therapeutic response, and disease outcome. His interest also extends to developmental hematopoiesis and the molecular mechanisms that underlie blood cell formation, which are critical in understanding both normal physiology and disease pathology. Stephen aims to explore immunological and molecular cell alterations in age-related and inflammatory diseases, such as autoimmune disorders, chronic infections, and degenerative conditions. A significant portion of his research is directed at identifying early diagnostic biomarkers for diseases prevalent in sub-Saharan Africa, including HIV/AIDS, tuberculosis, sickle cell disease, diabetes, and kidney disease. This demonstrates his commitment to applied biomedical research that has direct implications for public health and clinical practice. By focusing on early detection and molecular profiling, Stephen envisions contributing to the development of cost-effective and scalable diagnostic tools. His research orientation is not only academically relevant but also aligned with global health equity and the fight against non-communicable and infectious diseases.

Research Skills

Stephen Twumasi has developed a strong portfolio of research skills that align with modern biomedical research demands. His training in haematology and molecular biology equips him with the ability to conduct detailed laboratory analyses and interpret complex immunological data. He is proficient in diagnostic techniques related to blood disorders and has applied this expertise during his thesis research and laboratory coursework. His skills extend into bioinformatics and genomics, where he has gained practical knowledge through certified training programs. Stephen is also trained in systematic reviews and meta-analysis, enabling him to conduct high-level literature synthesis and evidence-based assessments. His familiarity with research writing and publication, gained through specialized workshops, enhances his ability to produce and disseminate scientific findings effectively. Stephen is knowledgeable in One Health approaches, showing his capacity to conduct interdisciplinary research that bridges human, animal, and environmental health. His training in community health entrepreneurship complements his scientific skills by adding a dimension of translational research and innovation. Overall, Stephen possesses a diverse set of skills—ranging from laboratory diagnostics to scientific writing and data interpretation—that prepare him for successful academic research and collaborative scientific work.

Awards and Honors

While there are no specific awards or honors listed in Stephen Twumasi’s current profile, his academic achievements and certifications reflect commendable performance and initiative. His excellent academic record, especially his strong performance in the M.Phil. Haematology program at KNUST, suggests merit-worthy scholarly effort. His pursuit of numerous competitive and high-impact short courses—offered by organizations such as the German-West Africa Center for Global Health, MasterCard Foundation, and Genomac Institute—also highlights his selection into esteemed training programs. These certifications are often reserved for promising young researchers who demonstrate a commitment to academic and research excellence. In addition, Stephen has shown proactive engagement in international and interdisciplinary learning environments, which is itself a testament to his academic motivation and research potential. As his research career progresses and he begins to publish his work and engage in more collaborative projects, he is likely to attract competitive fellowships, grants, and awards. While he may currently be at the formative stage of his academic recognition, Stephen’s trajectory and research readiness point toward future honors and distinctions as he contributes more substantively to the scientific community.

Conclusion

Stephen Twumasi is a dedicated and promising early-career researcher whose academic focus and professional development align with global health and biomedical priorities. With a robust educational foundation in haematology and medical laboratory science, complemented by strategic certifications in genomics, bioinformatics, One Health, and research writing, he has cultivated a multidisciplinary research profile. His interests in tumor immunology, hematopoiesis, and early diagnostics of infectious and chronic diseases reflect a strong commitment to improving health outcomes through science. While his formal professional roles and recognitions are still evolving, his proactive learning approach and research enthusiasm position him as a future leader in biomedical research. He has already demonstrated the capacity for scientific inquiry and critical analysis, supported by practical lab experience and theoretical understanding. With continued mentorship, opportunities for publication, and engagement in collaborative research, Stephen is well on the path to making impactful contributions to medical science and public health. He is a suitable candidate for research-focused awards and development programs, and his future holds promise as he builds on his strengths and expands his academic influence. His dedication to advancing diagnostic and molecular research makes him a valuable asset to the scientific and health communities.

Publications Top Notes

  1. Haemato‐urological profile and asymptomatic urinary tract infection in Ghanaian steady‐state sickle cell disease patients: A case‐control study
    📚 Health Science Reports
    📅 Year: 2025
    👥 Authors: Stephen Twumasi, Richard Owusu Ansah, Samuel Essien‐Baidoo, Laud Anthony W. Basing, Alexander Yaw Debrah, Enoch Odame Anto, Allwell Adofo Ayirebi, Rebecca Asiamah‐Broni, Waldemer Attivor, Eric Twum Ameyaw, et al.
    📈 Citations: Not available yet

  2. Assessing liver and iron markers in steady state paediatric SCD patients to ascertain the hepatic consequences of haemotransfusion: A case-control study in Ghana
    📄 Preprint
    📅 Year: 2024
    👥 Authors: John Agyemang Sah, Benedict Sackey, Enoch Odame Anto, Allwell Adofo Ayirebi, Stephen Twumasi, Richard Vikpebah Duneeh, Ebenezer Senu, Veronica Barnor, David Boakye, Daniel Nii Martey Antonio, et al.

  3. Haemato-urological profile and asymptomatic urinary tract infection in Ghanaian steady-state sickle cell disease patients
    📄 Preprint
    📅 Year: 2024
    👥 Authors: Stephen Twumasi, Richard Owusu Ansah, Samuel Essien-Baidoo, Laud Anthony W. Basing, Alexander Yaw Debrah, Enoch Odame Anto, Allwell Adofo Ayirebi, Rebecca Asiamah-Broni, Waldemer Attivor, Eric Twum Ameyaw, et al.

  4. Diagnostic value of neutrophil gelatinase-associated lipocalin and neutrophil-to-lymphocyte ratio in type 2 diabetes mellitus individuals with reduced estimated glomerular filtration rate (eGFR): A case-control study in a municipal hospital in Ghana
    📄 Preprint
    📅 Year: 2024
    👥 Authors: Allwell Adofo Ayirebi, Wina Ivy Ofori Boadu, Benedict Sackey, Lilian Antwi-Boateng, Prince Adoba, Patrick Adu, Joseph Boachie, Stephen Twumasi, Joseph Frimpong, Emmanuel Ekow Korsah, et al.

  5. Neutrophil gelatinase-associated lipocalin and fibrinogen-to-albumin ratio are indicators of nephropathy in adult steady state sickle cell disease patients: A multicenter case-control study in Ghana
    📄 Preprint
    📅 Year: 2024
    👥 Authors: Stephen Twumasi, Enoch Odame Anto, Christian Obirikorang, Richard Kobina Dadzie Ephraim, Benedict Sackey, Vivian Paintsil, Richard Owusu Ansah, Alfred Effah, Allwell Adofo Ayirebi, Angela Opoku, et al.

 

Shayan Yousufzai | Medicine and Dentistry | Young Scientist Award

Posted on by Shen Awards

Dr. Shayan Yousufzai | Medicine and Dentistry | Young Scientist Award

General practitioner and Clinical Research Fellow from Shiraz University of Medical Sciences, Iran

Dr. Shayan Yousufzai is a highly motivated physician and clinical researcher with a strong foundation in medical education, research, and academic writing. Having earned his Doctor of Medicine degree from Islamic Azad University of Medical Sciences in Shiraz, he has demonstrated a consistent commitment to integrating clinical excellence with evidence-based research. Dr. Yousufzai’s passion for scientific inquiry has led to an impressive portfolio of peer-reviewed publications and collaborations with both national and international researchers. His clinical exposure spans a range of specialties including pediatric, thoracic, vascular, and ENT surgery, enriching his multidisciplinary understanding of healthcare. Known for his professionalism, attention to detail, and collaborative spirit, he brings a unique blend of analytical thinking and practical medical skills to every project. Beyond medicine, Dr. Yousufzai is proficient in research tools, data analysis software, and academic writing platforms, enhancing his ability to contribute to high-quality scholarly outputs. His long-term vision centers on bridging the gap between clinical practice and research innovation, ultimately aiming to impact patient outcomes on a global scale. With a strong commitment to continuing education and scientific contribution, Dr. Yousufzai is emerging as a promising figure in the evolving landscape of clinical research and academic medicine.

Professional Profile

Education

Dr. Shayan Yousufzai pursued his medical education at the Islamic Azad University of Medical Sciences, Shiraz Branch, where he obtained his Doctor of Medicine (MD) degree. His academic journey was marked by distinction, leadership, and a strong inclination toward clinical research. During his medical training, he demonstrated exceptional academic performance while actively engaging in extracurricular and scholarly activities. His early exposure to complex medical cases during clinical rotations sparked a passion for surgery and scientific inquiry. He complemented his formal education with practical experiences in various hospitals, particularly in pediatric, thoracic, vascular, and ENT surgery. Recognizing the value of research in improving healthcare outcomes, Dr. Yousufzai sought out mentorship from senior clinicians and researchers, through which he gained expertise in data analysis, evidence-based practice, and academic writing. Beyond the classroom, he participated in workshops, training courses, and medical conferences that deepened his understanding of scientific methodology and global health issues. Additionally, he completed several certification courses that enhanced his clinical research capabilities, such as scientific writing, research ethics, and clinical trial design. His academic foundation has not only prepared him to navigate complex clinical environments but has also inspired a lifelong dedication to combining hands-on medical care with impactful research initiatives.

Professional Experience

Dr. Shayan Yousufzai has accumulated valuable professional experience through a combination of clinical practice and active participation in medical research. After earning his MD, he trained in several hospital settings where he handled patient care across a range of specialties, notably pediatric, thoracic, and vascular surgery. These immersive clinical experiences enabled him to develop strong diagnostic and procedural skills while working alongside seasoned professionals in high-pressure environments. Parallel to his clinical roles, Dr. Yousufzai embraced opportunities to contribute to research and academic writing. He collaborated with multidisciplinary teams on studies that spanned topics in general medicine, surgery, and public health. His contributions often included literature reviews, data interpretation, and manuscript development for submission to peer-reviewed journals. Notably, he played a key role in coordinating research projects that involved international collaboration, underscoring his communication and organizational strengths. His active involvement in conferences, both as an attendee and presenter, reflects his commitment to lifelong learning and knowledge dissemination. With a holistic view of medicine that encompasses both patient care and scientific advancement, Dr. Yousufzai’s professional experience positions him as a dynamic and capable contributor in the realms of clinical practice, research, and academic development.

Research Interests

Dr. Shayan Yousufzai’s research interests lie at the intersection of clinical medicine, public health, and translational research. He is particularly passionate about investigating the mechanisms of disease progression, evaluating treatment outcomes, and improving surgical practices through evidence-based methods. His research often focuses on multidisciplinary areas, including pediatrics, thoracic surgery, ENT disorders, and global health challenges. Dr. Yousufzai is also deeply interested in epidemiology, health policy, and the role of preventative care in reducing the burden of chronic disease. His involvement in diverse research initiatives demonstrates a strong commitment to enhancing clinical protocols and contributing to medical knowledge that directly benefits patients. Additionally, he has an interest in exploring the ethical and practical dimensions of healthcare delivery in resource-limited settings, aiming to inform interventions that are both sustainable and equitable. Dr. Yousufzai continuously seeks opportunities to apply innovative methodologies such as meta-analyses, clinical trials, and systematic reviews to generate high-impact findings. With a keen eye for scientific rigor and a collaborative mindset, his research endeavors are grounded in the goal of bridging clinical gaps and fostering health equity on a global scale.

Research Skills

Dr. Shayan Yousufzai possesses a diverse and comprehensive set of research skills that enhance his contributions to both academic and clinical studies. He is proficient in designing research protocols, conducting systematic reviews, and synthesizing evidence using meta-analytical tools. His academic training and hands-on experience have equipped him with strong capabilities in literature search strategies, critical appraisal, and hypothesis formulation. Dr. Yousufzai is well-versed in using software such as EndNote, Mendeley, and Zotero for reference management, and he has practical knowledge of SPSS and Excel for statistical analysis. He is skilled in data collection, survey design, and manuscript preparation, with multiple publications in peer-reviewed journals to his name. Moreover, his ability to collaborate across disciplines and manage research timelines makes him a valuable team member on complex projects. His familiarity with ethical research practices and regulatory requirements further adds to his credibility as a reliable researcher. In addition to his technical skills, Dr. Yousufzai excels in scientific writing and peer-review processes, allowing him to communicate complex findings with clarity and precision. His combined clinical insight and research acumen enable him to ask relevant questions and design studies that are both impactful and clinically applicable.

Awards and Honors

Throughout his academic and professional journey, Dr. Shayan Yousufzai has been recognized for his outstanding performance and dedication to medical research and clinical excellence. During his time at Islamic Azad University, he consistently ranked among the top students in his cohort, earning accolades for both academic and extracurricular achievements. His passion for research and scholarly writing has resulted in multiple publications in peer-reviewed international journals, some of which have gained recognition in academic circles. He has been acknowledged by peers and mentors alike for his contributions to collaborative projects, especially those involving multidisciplinary and cross-institutional teams. Additionally, Dr. Yousufzai has received certificates of excellence for his participation in research workshops, online medical training programs, and scientific writing courses. He has been invited to present his findings at several academic conferences, where his work was well-received and praised for its relevance and clarity. His ability to balance clinical responsibilities with academic research has earned him a reputation as a driven and dependable medical professional. These honors reflect his ongoing commitment to contributing meaningfully to the field of medicine, both in clinical practice and in the scientific community.

Conclusion

Dr. Shayan Yousufzai stands out as a promising figure in modern medicine, blending clinical expertise with a deep passion for scientific research. His academic background, enriched by hands-on clinical experience and extensive involvement in research projects, positions him to contribute meaningfully to both patient care and academic advancement. With a clear focus on evidence-based practice and a global health perspective, he exemplifies the qualities of a well-rounded physician-researcher. His proficiency in medical writing, data analysis, and collaboration makes him an asset in any academic or clinical setting. Moreover, his dedication to ethical practices and health equity underscores a commitment to impactful and compassionate medicine. As he continues to expand his research portfolio and clinical competencies, Dr. Yousufzai remains driven by a mission to improve healthcare delivery and outcomes through innovation and inquiry. Whether at the bedside or in the lab, his holistic approach to medicine ensures that he is not only a skilled practitioner but also a thought leader shaping the future of healthcare. His journey reflects a continuous pursuit of excellence, and his contributions are set to leave a lasting mark on the global medical and scientific community.

Publications Top Notes

  1. Title: First time use of trans-anal endorectal pull through (Soave procedure) for management of recurrent rectal mucosal prolapse in children not responding to the conventional sclerotherapy interventions: A case series
    Authors: A. Tadayon, H. Hosseini, O. Azh, Sh. Yousufzai, A. Rahmanian, M. Pourkhosravani
    Year: 2025

  2. Title: Genetic Insights Into Hyaline Fibromatosis Syndrome: A Case Report of an ANTXR2 Mutation Featuring a Rare Variant c.697+1G>A
    Authors: Shabnam Hajiani Ghotbabadi, Reza Shiari, Shayan Yousufzai, Simin Sharifi
    Year: 2025

  3. Title: Unveiling the uncommon: Cholesterol granuloma in the nasopharynx of a young patient
    Authors: Amir Soltaniesmaeili, Alireza Yousefi, Shayan Yousufzai, Sajjad Soltani, Zhale Mardani
    Year: 2025

  4. Title: Establishing Reliability and Validity of the Persian Pediatric Bowel Management Scoring Tool for Postoperative Care in Hirschprung’s Disease
    Authors: Omidreza Azh, Shayan Yousufzai, Hossein Hosseini, Mehdi Forooghi, Sahar Ghahramani, Reihane Pourmosavian, Sajede Radmard, Bisma Zulfiqar, Ali Ghorbanpour, Mostafa Pourkhosravani et al.
    Year: 2025

  5. Title: Adenoid cystic carcinoma of the tongue: A case study highlighting surgical management of an exceptionally rare entity
    Authors: Bijan Khademi, Sajjad Soltani, Shayan Yousufzai, Alireza Yousefi, Mohammad Ehsan Golshannia, Zhale Mardani
    Year: 2025

  6. Title: Lentigo maligna melanoma of the face: Clinical insights from a case of recurrence following surgical excision
    Authors: Seyed Basir Hashemi, Sajjad Soltani, Shayan Yousufzai, Negar Fatehi, Alireza Yousefi
    Year: 2025

  7. Title: Management of nasopharyngeal stenosis post-tonsillectomy using the Madame Butterfly technique: A case report with novel approach
    Authors: Amir Soltaniesmaeili, Fateme Farhadipour, Shayan Yousufzai, Hossein Hosseini, Saeed Farjam, Alireza Yousefi
    Year: 2025

  8. Title: Ocular invasion in sinonasal malignant melanoma: A case report and review of literature
    Authors: Bijan Khademi, Sajjad Soltani, Alireza Yousefi, Pouya Heidari, Zhale Mardani, Shayan Yousufzai
    Year: 2025

  9. Title: Cystic lymphangioma of the head and tail of the pancreas in a middle-aged Iranian woman: A case report
    Authors: Bizhan Ziaian, Ardalan Golbahar-Haghighi, Farzad Dalfardi, Shayan Yousufzai, Ali Sina Aloudal
    Year: 2024

  10. Title: A giant trichobezoar in a child with attention deficit hyperactivity disorder: A case report
    Authors: M. Forooghi, R. Shahrokhi, Sh. Yousufzai
    Year: 2024

Mrinalini Balki | Medicine and Dentistry | Best Researcher Award

Posted on by Shen Awards

Dr. Mrinalini Balki | Medicine and Dentistry | Best Researcher Award

Professor from Mount Sinai Hospital, University of Toronto, Canada

Dr. Mrinalini Balki is a distinguished anesthesiologist and researcher specializing in obstetric anesthesia. With over two decades of experience in clinical practice and academia, she has significantly contributed to advancing maternal healthcare. She is a professor at the University of Toronto and a Senior Clinician Scientist at the Lunenfeld-Tanenbaum Research Institute. Dr. Balki’s research focuses on optimizing anesthetic techniques for labor and delivery, ensuring safer outcomes for mothers and newborns. Her extensive publication record and numerous national and international awards underscore her influence in the field. Throughout her career, she has combined clinical expertise with pioneering research, addressing critical challenges in anesthesia and obstetric care. She has also played a pivotal role in mentoring future anesthesiologists and researchers, fostering innovation and excellence. Recognized globally, her work has shaped the understanding of myometrial contractility, uterotonic agents, and anesthetic safety in obstetric patients. Her ongoing commitment to high-impact research, education, and clinical excellence positions her as a leading figure in her field. Dr. Balki’s dedication to improving patient safety, combined with her impressive research credentials, makes her a strong contender for the Best Researcher Award.

Professional Profile

Education

Dr. Balki has an extensive academic background in medicine and anesthesiology. She earned her Bachelor of Medicine and Bachelor of Surgery (MBBS) degree from Nagpur University, India, in 1994. She subsequently completed her Doctor of Medicine (MD) in Anesthesiology from Nagpur University in 1997, achieving specialist certification from the Maharashtra Medical Council. To further refine her expertise, she pursued multiple fellowships at the University of Toronto. From 2001 to 2004, she completed clinical and research fellowships in anesthesia, neuroanesthesia, and obstetric anesthesia at Toronto’s leading hospitals, including Mount Sinai Hospital, Toronto Western Hospital, and St. Michael’s Hospital. In addition to these achievements, Dr. Balki has obtained several professional certifications, including the Licentiate of the Medical Council of Canada (LMCC) in 2002 and certification in Neonatal Resuscitation in 2003. She has also successfully cleared the United States Medical Licensing Examination (USMLE) Step 1 & 2. Her continuous commitment to learning and updating her medical skills is further demonstrated by her Advanced Cardiac Life Support (ACLS) certification in 2025. Dr. Balki’s extensive education, combined with her postgraduate research training, has laid the foundation for her successful career in anesthesiology and research.

Professional Experience

Dr. Balki has an impressive professional background, spanning both clinical and academic roles. Since 2004, she has been an active staff member in the Department of Anesthesia at Mount Sinai Hospital, Toronto, where she provides expert anesthetic care, particularly in obstetric and perioperative anesthesia. She also holds clinical appointments at the Kensington Eye Institute and Women’s College Hospital. Academically, she has served at the University of Toronto for over two decades, progressing from Assistant Professor in 2004 to full Professor in 2021. She is a faculty member in the departments of Anesthesia, Obstetrics and Gynecology, and Physiology, reflecting her interdisciplinary expertise. Dr. Balki has also contributed to research as a Senior Clinician Scientist at the Lunenfeld-Tanenbaum Research Institute since 2017. Her prior experience includes clinical appointments at the Centre for Addiction and Mental Health and University Health Network, further broadening her expertise. Internationally, she worked as a Staff Anesthesiologist in India before relocating to Canada. Her career reflects a strong combination of clinical excellence, academic leadership, and research innovation, making her a respected authority in the field of anesthesiology.

Research Interests

Dr. Balki’s primary research interest lies in obstetric anesthesia, particularly optimizing uterotonic drug administration and improving maternal outcomes. She has conducted extensive research on myometrial contractility, focusing on how various uterotonic agents interact with oxytocin to enhance or inhibit contractions during labor and postpartum hemorrhage treatment. Her work has significant implications for developing safer and more effective anesthesia protocols in obstetric care. Additionally, she is interested in maternal hemodynamics, pain management techniques during labor, and the effects of anesthetic drugs on both mother and fetus. Simulation-based medical education is another area of her research, aiming to improve interdisciplinary teamwork in obstetric crisis management. Her studies have influenced clinical guidelines and best practices in obstetric anesthesia. Dr. Balki is also involved in translational research, bridging the gap between laboratory findings and real-world clinical applications. Her interdisciplinary approach integrates pharmacology, anesthesiology, and obstetrics, ensuring a comprehensive understanding of maternal physiology and anesthetic response. Through her research, she continues to contribute to advancements in anesthesia safety, pain control, and maternal health outcomes.

Research Skills

Dr. Balki possesses a diverse set of research skills that have contributed to her success as a leading investigator in anesthesiology. She has expertise in designing and conducting randomized controlled trials, allowing her to generate high-quality clinical evidence. Her proficiency in in-vitro research methods has enabled her to explore myometrial contractility under various conditions, leading to innovative findings in obstetric pharmacology. She is skilled in advanced statistical analysis, ensuring data-driven decision-making in her research. Dr. Balki also excels in medical simulation-based research, using high-fidelity simulations to evaluate clinical teamwork and response to obstetric emergencies. She has experience in grant writing, securing significant funding for her studies. Additionally, her ability to collaborate with multidisciplinary teams, including anesthesiologists, obstetricians, and pharmacologists, has strengthened her research output. She is well-versed in systematic reviews and meta-analyses, allowing her to synthesize existing knowledge and identify research gaps. Her strong publication record, combined with her ability to translate research findings into clinical practice, demonstrates her exceptional research capabilities.

Awards and Honors

Dr. Balki has received numerous prestigious awards, reflecting her excellence in research and clinical practice. Internationally, she has been honored multiple times by the Society for Obstetric Anesthesia and Perinatology, receiving the esteemed Zuspan Award in 2006, 2009, 2010, and 2014. She has also won several Best Paper Awards, including at the Canadian Anesthesiologists’ Society Annual Meetings in 2008, 2009, 2011, 2012, 2016, and 2020. Her contributions to patient safety and medical education have been recognized with the Patient Safety Award and Research in Education Award in 2015. She was also awarded the Canadian Anesthesiologists’ Society Career Scientist Award and the Dr. R. A. Gordon Research Award. In addition to her received awards, she has been nominated multiple times for the Richard Knill Award, further affirming her impact on anesthesiology research. These recognitions highlight her consistent contributions to advancing knowledge and improving clinical practices in obstetric anesthesia.

Conclusion

Dr. Mrinalini Balki is a highly accomplished researcher whose work has made significant contributions to the field of anesthesiology, particularly in obstetric care. Her extensive research, spanning clinical trials and laboratory studies, has influenced maternal healthcare practices worldwide. Her leadership in academia, combined with her clinical expertise, has positioned her as a key figure in anesthesiology research. She has received multiple prestigious awards, reflecting her dedication to excellence and innovation. While her research primarily focuses on obstetric anesthesia, expanding collaborations in broader anesthesia fields and public health policy could further enhance her impact. Her exceptional research skills, commitment to education, and ability to translate findings into improved patient care make her a deserving candidate for the Best Researcher Award. Dr. Balki’s continued contributions to scientific advancements in anesthesia will undoubtedly shape the future of maternal and perioperative healthcare.

Publications Top Notes

  1. Title: Oxytocin versus carbetocin at elective Cesarean delivery in parturients with class III obesity: a double-blind randomized controlled noninferiority trial
    Authors: W. Turner, William; L. Boonstra, Linda; C.V. Maxwell, Cynthia V.; K.N. Downey, Kristi N.; M. Balki, Mrinalini
    Year: 2025

  2. Title: Maintenance infusion rate of oxytocin after initial 1-IU bolus for elective Cesarean delivery: a dose-finding study
    Authors: L. Boonstra, Linda; J.C.A. Carvalho, José Carlos Almeida; W. Turner, William; J.A. Thomas, Jackie A.; M. Balki, Mrinalini
    Year: 2024
    Citations: 1

  3. Title: Differential sensory block during labour epidural analgesia: a prospective observational study to investigate the relationship of lower and upper sensory block levels to cold, pinprick, and light touch
    Authors: J.F. Casellato, Julia F.; M. Balki, Mrinalini; A. Wang, Andrew; K.N. Downey, Kristi N.; J.C.A. Carvalho, José Carlos Almeida
    Year: 2024
    Citations: 4

  4. Title: In Response
    Authors: E. Peska, Emil; M. Balki, Mrinalini; W. Pfeifer, Wesla; K.N. Downey, Kristi N.; J.C.A. Carvalho, José Carlos Almeida

  5. Title: Oxytocin at Elective Cesarean Delivery: A Dose-Finding Study in Pregnant People with Twin Pregnancy
    Authors: E. Peska, Emil; M. Balki, Mrinalini; W. Pfeifer, Wesla; K.N. Downey, Kristi N.; J.C.A. Carvalho, José Carlos Almeida
    Year: 2024
    Citations: 4

  6. Title: Carbetocin vs. oxytocin at elective caesarean delivery: a reply
    Authors: M. Balki, Mrinalini; F. McDonagh, F.; J.C.A. Carvalho, José Carlos Almeida

  7. Title: In Response
    Authors: O.F.C. van den Bosch, Oscar F.C.; R.A. Chaudhry, Rabail Arif; J. Wicker, James; L. Munshi, Laveena; M. Balki, Mrinalini

  8. Title: Predictors and Hospital Outcomes in Pregnant Patients Undergoing Extracorporeal Membrane Oxygenation: A Nationwide Study
    Authors: O.F.C. van den Bosch, Oscar F.C.; R.A. Chaudhry, Rabail Arif; J. Wicker, James; L. Munshi, Laveena; M. Balki, Mrinalini
    Year: 2022
    Citations: 13

  9. Title: Association of body fluid distribution with obstructive sleep apnea in pregnant individuals with a body mass index ≥ 40 kg·m²—a prospective observational feasibility study
    Authors: J. Wicker, James; C.V. Maxwell, Cynthia V.; K.N. Downey, Kristi N.; M. Singh, Mandeep; M. Balki, Mrinalini

  10. Title: General anesthesia for Cesarean delivery in a parturient critically ill with COVID-19: a case report
    Authors: B. Kaminski, Bradley; W. Turner, William; M. Virdee, Misha; W.L. Whittle, Wendy L.; M. Balki, Mrinalini

 

Jonathan Super | Medicine and Dentistry | Best Researcher Award

Posted on by Shen Awards

Mr. Jonathan Super | Medicine and Dentistry | Best Researcher Award

Royal Infirmary of Edinburgh, United Kingdom

Jonathan Thomas Matthew Super is a dedicated medical professional and researcher with expertise in trauma and orthopaedics. He holds an MBBS from Imperial College London and a First-Class Honours BSc in Exercise and Sport Sciences from Exeter University. With a strong clinical background and an impressive publication record, he has contributed extensively to orthopaedic research, focusing on biomechanics, surgical techniques, and healthcare inequalities. His work has been recognized through multiple commendations and awards, including the Wildcard Prize at the South East Scotland Orthopaedic Research Day. Jonathan’s ability to merge clinical practice with research has positioned him as a promising figure in the field of orthopaedics.

Professional Profile

Education

Jonathan Super completed his MBBS at Imperial College London between 2013 and 2020. During this time, he also pursued an intercalated BSc in Exercise and Sport Sciences at Exeter University, graduating with First-Class Honours in 2018. His early education at Solihull School was marked by academic excellence, earning 10 A*s at GCSE and A-levels in Chemistry, Biology, Mathematics, and Latin. He has further demonstrated his commitment to medical education by successfully passing the Intercollegiate MRCS examinations, solidifying his foundation in surgical sciences and clinical practice. His educational achievements reflect his dedication to both medicine and research.

Professional Experience

Jonathan’s clinical experience spans multiple specialties, with a primary focus on trauma and orthopaedics. Since August 2022, he has been undergoing Specialty Training in Trauma and Orthopaedics in the South East Scotland Rotation. Prior to this, he completed his Foundation Year training at Maidstone and Tunbridge Wells NHS Trust, gaining experience in orthogeriatric medicine, accident and emergency, otolaryngology, gastroenterology, general surgery, and liaison psychiatry. During the COVID-19 pandemic, he served as a volunteer and interim foundation doctor at St Mary’s Hospital, Paddington, showcasing his resilience and commitment to patient care. His diverse clinical background strengthens his ability to conduct research that is directly relevant to medical practice.

Research Interest

Jonathan’s research interests lie at the intersection of orthopaedic surgery, biomechanics, and healthcare disparities. He has explored topics such as biologic augmentation of meniscus repair, intra-articular injections for knee osteoarthritis, and survivorship outcomes in total ankle arthroplasty. Additionally, he has contributed to research on burnout in postgraduate trainees and the impact of socioeconomic status on medical training. His work highlights a commitment to improving both surgical techniques and the broader healthcare system. By addressing both clinical and systemic issues, Jonathan aims to advance the quality of patient care while also shaping medical education and policy.

Research Skills

Jonathan has developed a strong skill set in research methodologies, data analysis, and clinical trials. He is proficient in systematic reviews, retrospective cohort studies, and qualitative research. His ability to work with large datasets and analyze outcomes in orthopaedic surgery has led to multiple peer-reviewed publications. Additionally, he has experience in manuscript writing, grant applications, and conference presentations. His collaborative work with multidisciplinary teams further demonstrates his ability to contribute effectively to complex research projects. His research skills not only support his academic contributions but also ensure that his findings have practical applications in clinical practice.

Awards and Honors

Jonathan has received several academic and professional accolades throughout his career. At Imperial College London, he earned a Merit in Psychiatry, while his time at Exeter University was marked by a Dean’s Commendation and a Sport and Health Sciences Commendation for Academic Performance. His undergraduate research was recognized with the Human Kinetics Prize for Best Dissertation Poster. More recently, he was awarded the Wildcard Prize at the South East Scotland Orthopaedic Research Day in 2024. His achievements reflect both academic excellence and a commitment to advancing medical knowledge.

Conclusion

Jonathan Super has established himself as a dedicated clinician and researcher in the field of orthopaedics. His strong academic foundation, diverse clinical experience, and extensive research contributions position him as a promising candidate for prestigious scientific recognition. While he has already made significant strides in orthopaedic research, further leadership roles, independent research funding, and international collaborations would enhance his impact in the field. His commitment to advancing medical science and improving patient outcomes underscores his potential as a distinguished scientist.

Publications Top Notes

  • Title: 30-day morbidity and mortality of bariatric surgery during the COVID-19 pandemic: a multinational cohort study of 7704 patients from 42 countries
    Authors: R. Singhal, C. Ludwig, G. Rudge, G.V. Gkoutos, A. Tahrani, K. Mahawar, …
    Year: 2021
    Citations: 54

  • Title: 30-day morbidity and mortality of sleeve gastrectomy, Roux-en-Y gastric bypass and one anastomosis gastric bypass: a propensity score-matched analysis of the GENEVA data
    Authors: R. Singhal, V.R. Cardoso, T. Wiggins, J. Super, C. Ludwig, G.V. Gkoutos, …
    Year: 2022
    Citations: 46

  • Title: Waiting lists for symptomatic joint arthritis are not benign: prioritizing patients for surgery in the setting of COVID-19
    Authors: J.A. Morris, J. Super, D. Huntley, T. Ashdown, W. Harland, R. Anakwe
    Year: 2020
    Citations: 33

  • Title: Effect of COVID-19 pandemic on global bariatric surgery practices – The COBRAS study
    Authors: R. Singhal, A.A. Tahrani, N. Sakran, M. Herrera, V. Menon, M. Khaitan, …
    Year: 2021
    Citations: 27

  • Title: 30‐Day morbidity and mortality of bariatric metabolic surgery in adolescence during the COVID‐19 pandemic – The GENEVA study
    Authors: R. Singhal, T. Wiggins, J. Super, A. Alqahtani, E.P. Nadler, C. Ludwig, …
    Year: 2021
    Citations: 18

  • Title: Current concepts in the management of bisphosphonate-associated atypical femoral fractures
    Authors: B. Rudran, J. Super, R. Jandoo, V. Babu, S. Nathan, E. Ibrahim, A.V. Wiik
    Year: 2021
    Citations: 16

  • Title: Open tibia/fibula in the elderly: a retrospective cohort study
    Authors: A. Lee, L. Geoghegan, G. Nolan, K. Cooper, J. Super, M. Pearse, S. Naique, …
    Year: 2022
    Citations: 15

  • Title: Triaging of respiratory protective equipment on the assumed risk of SARS-CoV-2 aerosol exposure in patient-facing healthcare workers delivering secondary care: a rapid review
    Authors: P. Ramaraj, J. Super, R. Doyle, C. Aylwin, S. Hettiaratchy
    Year: 2020
    Citations: 12

  • Title: FFP3 Feelings and Clinical Experience (FaCE). Facial pressure injuries in healthcare workers from FFP3 masks during the COVID-19 pandemic
    Authors: R.M. Kwasnicki, J.T. Super, P. Ramaraj, L. Savine, S.P. Hettiaratchy
    Year: 2022
    Citations: 11

  • Title: 30-day morbidity and mortality of sleeve gastrectomy, Roux-en-Y gastric bypass and one anastomosis gastric bypass: A propensity score-matched analysis of the GENEVA data
    Authors: R. Singhal, V.R. Cardoso, T. Wiggins, J. Super, C. Ludwig, G.V. Gkoutos, …
    Year: 2022
    Citations: 7